In addition, because ZEB1 and Twist1 are established markers of EMT, the concurrent increase in their expression alongside CD26 suggests a potential association between elevated CD26 levels and the progression of EMT in CRC cells. The gene discussed is TWIST1; the disease is colorectal carcinoma.